Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP804251.RABRiwhdrststEN7IkkcUl2vwcsbvynAusJpUG3KsZt7Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP804251.RABRiwhdrststEN7IkkcUl2vwcsbvynAusJpUG3KsZt7Y130_assertion type Assertion NP804251.RABRiwhdrststEN7IkkcUl2vwcsbvynAusJpUG3KsZt7Y130_head.
- NP804251.RABRiwhdrststEN7IkkcUl2vwcsbvynAusJpUG3KsZt7Y130_assertion wasGeneratedBy ECO_0000203 NP804251.RABRiwhdrststEN7IkkcUl2vwcsbvynAusJpUG3KsZt7Y130_provenance.
- NP804251.RABRiwhdrststEN7IkkcUl2vwcsbvynAusJpUG3KsZt7Y130_assertion wasDerivedFrom befree-2016 NP804251.RABRiwhdrststEN7IkkcUl2vwcsbvynAusJpUG3KsZt7Y130_provenance.
- NP804251.RABRiwhdrststEN7IkkcUl2vwcsbvynAusJpUG3KsZt7Y130_assertion SIO_000772 2037012 NP804251.RABRiwhdrststEN7IkkcUl2vwcsbvynAusJpUG3KsZt7Y130_provenance.
- NP804251.RABRiwhdrststEN7IkkcUl2vwcsbvynAusJpUG3KsZt7Y130_assertion evidence source_evidence_literature NP804251.RABRiwhdrststEN7IkkcUl2vwcsbvynAusJpUG3KsZt7Y130_provenance.
- NP804251.RABRiwhdrststEN7IkkcUl2vwcsbvynAusJpUG3KsZt7Y130_assertion description "[Hypodense activated eosinophils have been described in various diseases such as parasitic or allergic diseases, hypereosinophilic syndrome (HES) associated in some cases to myeloproliferative markers, and more recently described in patients undergoing recombinant IL2 treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP804251.RABRiwhdrststEN7IkkcUl2vwcsbvynAusJpUG3KsZt7Y130_provenance.